Oncocross Patents – Insights & Stats (Updated 2023)

Oncocross has a total of 102 patents globally, out of which 35 have been granted. Of these 102 patents, more than 79% patents are active. Korea (South) is where Oncocross has filed the maximum number of patents, followed by United States of America and Japan. Parallelly, Korea (South) seems to be the main focused R&D centre and also is the origin country of Oncocross.

Oncocross was founded in 2015. Oncocross is an AI-based drug development biotech company. The company developed transcriptome data-based AI platforms and develops its own pipelines and collaborates with pharmaceutical companies.

Do read about some of the most popular patents of Oncocross which have been covered by us in this article and also you can find Oncocross patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Oncocross patent portfolio.

How many patents does Oncocross have?

Oncocross has a total of 102 patents globally. These patents belong to 37 unique patent families. Out of 102 patents, 81 patents are active.

How Many Patents did Oncocross File Every Year?

Oncocross Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantOncocross Applications FiledOncocross Patents Granted
202329
2022207
20212014
2020171
2019141
2018142
201721
201612
20151

How many Oncocross patents are Alive/Dead?

Worldwide Patents

Oncocross Patent Portfolio

How Many Patents did Oncocross File in Different Countries?

Oncocross Worldwide Patent Filing

Countries in which Oncocross Filed Patents

CountryPatent
Korea (South)38
United States of America8
Japan6
Europe4
Australia4
Canada3
China3
India2
Viet Nam2
Singapore1
Hong Kong (S.A.R.)1
Thailand1
South Africa1
Russia1
Malaysia1
Indonesia1
Philippines1

Where are Research Centers of Oncocross Patents Located?

The Research Centers of Oncocross Patents is the Korea (South).

What Percentage of Oncocross US Patent Applications Were Granted?

Oncocross (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 75%.

Below are the key stats of Oncocross patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Oncocross?

Law FirmTotal ApplicationsSuccess Rate
Potomac Law Group Pllc3100.00%
Harness Dickey St Louis20%
Sughrue Mion Pllc2100.00%
Schwegman Lundberg & Woessner PA10.00%

What are Oncocross key innovation segments?

What Technologies are Covered by Oncocross?

The chart below distributes patents filed by Oncocross in different countries on the basis of the technology protected in patents. It also represents the markets where Oncocross thinks it’s important to protect particular technology inventions.

R&D Focus: How has Oncocross search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Oncocross?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.